Status:
UNKNOWN
The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18-80 years
Brief Summary
Ovarian cancer is the first in mortality rate of the gynecologic malignancies and the overall 5-year survival rate of ovarian cancer is only 20-30%. Besides, the incidence of ovarian cancer increased ...
Detailed Description
Incidence of Ovarian Cancer: Ovarian cancer is the first in mortality rate of the gynecologic malignancies with an overall 5-year survival rate of only 20-30%. It became a more and more important dis...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy volunteers and ovarian cancer patients will be enrolled from the investigators' department under the approval of the Institutional Review Board.
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
End Date :
December 1 2008
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00173394
Start Date
August 1 2005
End Date
December 1 2008
Last Update
December 19 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan